Virpax Pharmaceuticals, Inc.
VRPXDelisted Jul 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708331
Virpax Pharmaceuticals, Inc. was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Jul 10, 2024; 7 institutions reported holding it in 13F filings for Q1 2025, worth $34.9K in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Virpax Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 16 | 16 | 0 |
| Shares | 2.49M | 1.87M | −620.1K (−24.9%) |
| Value | $3.29M | $3.13M | −$153.0K (−4.7%) |
New holders (3)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 11,380 | $19.0K | 0.00% |
| Quantum Private Wealth, LLC | 10,000 | $16.0K | 0.01% |
| Tower Research Capital LLC (TRC) | 2,602 | $4.00K | 0.00% |
Sold out (3)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Kepos Capital LP | 750,000 | $1.67M |
| Citigroup Inc | 12,179 | $27.0K |
| JPMorgan Chase & Co | 2,689 | $6.00K |